Intervention of the Prime Minister at the session "Health and Prosperity Through Prevention". World Economic Forum 2025

Spain Pedro Sánchez · Prime Minister of Spain

22 January 2025 · Session "Health and Prosperity Through Prevention", World Economic Forum 2025

Context
Sánchez spoke at the World Economic Forum 2025 session on health and prosperity through prevention, outlining Spain's healthcare innovation and global health commitments.
Main themes
Global health governance, public-private collaboration in healthcare, innovation in public health systems, Spain's healthcare leadership, equitable access to medicines, clinical trials, health financing, WHO and multilateral organizations, Gavi and Global Fund, precision medicine and advanced therapies, primary care, international health cooperation
Duration
~7 min
25th percentile
Words
850
25th percentile
Sentences
47
30th percentile
Readability
41
39th percentile
Grade
11.9
44th percentile
Syntax
3.02
50th percentile
Vocabulary
2.08
23rd percentile

World Economic Forum · Davos Translated from Spanish

Content
Actors
Style

The broad sphere of national life a sentence belongs to. Every sentence has an Arena, so it is the denominator the other indices are read against.

Other
  • Social 35%32%
  • Ceremonial 26%23%
  • Economic 19%17%
  • Institutional 14%13%
  • Technological 5%4%
  • Geopolitical 2%2%
  • Environmental 0%0%
  • Not in focus 9%

47 sentences in 27 paragraphs

Magdalena Skipper.- Mr. President, allow me to start with you.

Spain has shown a strong commitment to global health, including significant contributions to Gavi and the Global Fund.

How is Spain fostering innovation and the use of advanced technologies within its own healthcare system, and what can these experiences contribute regarding global health inequalities?

President.- Well, first of all, thank you very much for this question. And, of course, thank you for your invitation.

I believe that the COVID-19 pandemic made it clear that health is not an individual issue, but a collective responsibility, and this is something we can also apply to innovation. In two ways, essentially.

First, governments, the public sector, have the responsibility to ensure that the innovation model responds to health needs and also to accessibility.

Today we are witnessing a technological revolution that offers new hope for improving global health. But profitability cannot be the only driver of innovation. Thus, public health is a fundamental pillar for the development of new medicines and health technologies.

I believe it is not true that the public sector cannot innovate. On the contrary, a coherent public health infrastructure is a prerequisite for innovation in collaboration with the private sector.

My country is currently a leader in clinical trials in Europe and the third in the world, thanks to a network of internationally recognized centers of excellence and an extensive hospital network. And, of course, our primary care network plays an important supporting role in research.

And, secondly, public-private collaboration is essential. Spain is investing in this approach. Back in 2021, we launched an innovative public-private collaboration project in health: the strategic cutting-edge health project, with over 2.5 billion euros invested. And we have just launched a strategy for the pharmaceutical industry in collaboration with major pharmaceutical associations.

The goal is to promote innovation and equitable access to medicines, especially in advanced therapies and precision medicine.

So, you know, I believe this approach to public and private cooperation is essential to advance in this innovation approach you asked about.

Magdalena Skipper.- Really interesting and important examples. Thank you, and I really appreciated your comment and your emphasis on the fact that you believe innovation can occur in the public space. I think it is very important to remember that.

And, of course, that emphasis on public-private collaboration, where each of the stakeholders brings something new to that collaboration.

And in some of the other sessions, we have heard about this important tension between collaboration and competition and how both, in balance, in healthy balance, can really stimulate innovation.

Allow me to continue with the second question, and that is that in your examples you have already illustrated that Spain is a leader in international collaborations.

For example, you have talked about clinical trials, what strategies are being applied to support those international collaborations and to address health challenges and potential disparities in the world? Because, of course, what you and your government apply in Spain can be a magnificent example for the rest of the world.

President.- First of all, Spain has supported and will continue to support global health initiatives such as Gavi and the Global Fund.

And I believe this represents a joint effort of governments, but also of academia, multilateral organizations, civil society, and private initiatives united to improve access to the necessary health services to make the right to health effective.

And, secondly, we will also promote a more inclusive, efficient, and transparent global health governance that allows for better outcomes.

What we are witnessing is a change, Magdalena, in the global health financing cycle, and that implies a risk of regression in many parts of the world. And I believe we need to reverse this trend. And for that, we need to be more efficient. And in this sense, innovation can play a fundamental role in this context.

Global health governance responds to a multiplicity of actors and instruments that must be harmonized. And we will support multilateral governance that is effective, democratic, and representative, with the World Health Organization at its center.

And last but not least, what we want from Spain is to establish ourselves as a strategic partner in international cooperation and global health governance.

We are working on a global health strategy across the government to bring more coherence among the Spanish stakeholders.

And I am very pleased to express our hope that, after 20 years, Spain will return to the Executive Board of the World Health Organization in 2025 with a clear objective, which is to promote health as a global policy and a primary care approach to effectively address the challenges of changing social determinants of health and climate change, and, of course, mental health.

Q.- Thank you for sharing this with us. And this is certainly a great opportunity. It is very clear. You are taking it very seriously.

And thank you also for introducing into the conversation governance, the importance of global governance, global health, and finance, reimagining finance. I think it is an important topic, which is, of course, a very broad topic in itself.